Shionogi & Co., Ltd.
JPX: 4507.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Isao Teshirogi
- Employees
- 4,955
- Headquarters
- Osaka, Japan
- IPO year
- 2000
- Market cap
- ¥2.7T
- Website
- https://www.shionogi.com
Loading 4507…
Loading profile data…Frequently asked questions about 4507
What does Shionogi & Co., Ltd. (4507.T) do?
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Xofluza, an influenza virus drug; and Tivicay for HIV treatment. It also develops Symproic for op...
Where does 4507.T trade?
Shionogi & Co., Ltd. (4507.T) trades on the Tokyo Stock Exchange.
What sector is 4507.T in?
Shionogi & Co., Ltd. (4507.T) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Shionogi & Co., Ltd.?
Isao Teshirogi is the chief executive officer of Shionogi & Co., Ltd. (4507.T).
Where is Shionogi & Co., Ltd. headquartered?
Shionogi & Co., Ltd. is headquartered in Japan.
Does 4507.T pay a dividend?
Yes — Shionogi & Co., Ltd. (4507.T) paid a trailing twelve-month dividend of JPY 71.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 4507.T go public?
Shionogi & Co., Ltd. (4507.T) completed its initial public offering in 2000.